The DOI matches its Crossref record; 123 of the 126 references it cites were found in a registry or an index.
Dysregulated relationship of inflammation and oxidative stress in major depression
Open accessAbstract
Chronic inflammation and oxidative stress have been implicated in the pathophysiology of Major Depressive Disorder (MDD), as well as in a number of chronic medical conditions. The aim of this study was to examine the relationship between peripheral inflammatory and oxidative stress markers in un-medicated subjects with MDD compared to non-depressed healthy controls and compared to subjects with MDD after antidepressant treatment. We examined the relationships between IL-6, IL-10, and the IL-6/IL-10 inflammatory ratio vs. F2-isoprostanes (F2-IsoP), a marker of oxidative stress, in un-medicated MDD patients (n=20) before and after 8 weeks of open-label sertraline treatment (n=17), compared to healthy non-depressed controls (n=20). Among the un-medicated MDD subjects, F2-IsoP concentrations were positively correlated with IL-6 concentrations (p<0.05) and were negatively correlated with IL-10 concentrations (p<0.01). Accordingly, F2-IsoP concentrations were positively correlated with the ratio of IL-6/IL-10 (p<0.01). In contrast, in the control group, there were no significant correlations between F2-IsoPs and either cytokine or their ratio. After MDD subjects were treated with sertraline for 8 weeks, F2-IsoPs were no longer significantly correlated with IL-6, IL-10 or the IL-6/IL-10 ratio. These data suggest oxidative stress and inflammatory processes are positively associated in untreated MDD. Our findings are consistent with the hypothesis that the homeostatic buffering mechanisms regulating oxidation and inflammation in healthy individuals become dysregulated in untreated MDD, and may be improved with antidepressant treatment. These findings may help explain the increased risk of comorbid medical illnesses in MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“DAMPs that are known to activate NLRP3 are increased in patients with mood disorders, with examples including HSPs, reactive oxygen species and other markers of oxidative stress such as xanthine oxidase, peroxides and F2-isoprostanes51–53.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [52]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In depression, OS plays a crucial role. 131 , 132”
From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Kemp, F. (2003) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.1046/j.1467-9884.2003.t01-2-00383_4.x · Cited by 9,294
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Preacher, K. J., Curran, P. J., & Bauer, D. J. (2006) · Journal of Educational and Behavioral Statistics · doi:10.3102/10769986031004437 · Cited by 5,044
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Accelerated telomere shortening in response to life stress
Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407162101 · Cited by 3,002
Self-citationThioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
Hayes, A. F., & Matthes, J. (2009) · Behavior Research Methods · doi:10.3758/brm.41.3.924 · Cited by 2,452
Flagged first, then by citations
3 of the 126 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- First, M.B., Spitzer, RL., Gibbon, M. (2002). Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York State Psychiatric Institute Biometrics Research.
Cited by
Sorted by citations
Items 101–200 of 255
Li, L., & Dai, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.01.200 · Cited by 41
Yang, R., Lu, B., Li, T., Du, Y., Wang, X., & Jia, Y. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4315 · Cited by 40
Cline, B. H., Anthony, D. C., Lysko, A., Dolgov, O., Anokhin, K. V., Schroeter, C. A., Malin, D., Kubatiev, A. A., Steinbusch, H. W. M., Lesch, K., et al. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.037 · Cited by 42
Joshi, P., Bisht, A., Joshi, S., Semwal, D. K., Nema, N. K., Dwivedi, J., & Sharma, S. K. (2022) · Phytotherapy Research · doi:10.1002/ptr.7522 · Cited by 39
Wang, P., Feng, Y.-B., Wang, L., Li, Y., Fan, C., Song, Q., & Yu, S. Y. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.08.002 · Cited by 38
Liu, P., Bai, X., Zhang, T., Zhou, L., Li, J., & Zhang, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.64 · Cited by 37
Association between single nucleotide polymorphisms of MUTYH, hOGG1 and NEIL1 genes, and depression
Czarny, P. L., Kwiatkowski, D., Gałecki, P., Talarowska, M. E., Orzechowska, A., Bobińska, K., Bielecka-Kowalska, A., Szemraj, J., Maes, M. H. J., Su, K., et al. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.044 · Cited by 36
Characteristics and cellular effects of ambient particulate matter from Beijing
Lu, Y., Su, S., Jin, W., Wang, B., Li, N., Shen, H., Li, W., Huang, Y., Chen, H., Zhang, Y., et al. (2014) · Environmental Pollution · doi:10.1016/j.envpol.2014.04.008 · Cited by 36
Doggui, R., Elsawy, W., Conti, A. A., & Baldacchino, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.031 · Cited by 36
Wang, G., Wang, Y., Wang, C., Huang, C., & Jia, N. (2019) · The Analyst · doi:10.1039/c9an01934k · Cited by 35
Eisendrath, S. J., Gillung, E., Delucchi, K., Mathalon, D. H., Yang, T. T., Satre, D. D., Rosser, R., Sipe, W. E. B., & Wolkowitz, O. M. (2015) · Mindfulness · doi:10.1007/s12671-014-0280-8 · Cited by 34
“A description and the results of that trial have been previously published (Rawdin et al., 2012).”
BackgroundSelf-citationLindqvist, D., Mueller, S., Mellon, S. H., Su, Y., Epel, E. S., Reus, V. I., Rosser, R., Mahan, L., Mackin, R. S., Yang, T. T., et al. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.09.002 · Cited by 33
Self-citationMajor Depressive Disorder and Measures of Cellular Aging: An Integrative Review
Kinser, P. A., & Lyon, D. (2013) · Nursing Research and Practice · doi:10.1155/2013/469070 · Cited by 34
Individual differences in inflammatory and oxidative mechanisms of stress-related mood disorders
Kalinichenko, L. S., Kornhuber, J., & Müller, C. P. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.100783 · Cited by 35
Ibrahim, W. W., Ismail, H. M., Khattab, M. M., & Abdelkader, N. F. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115028 · Cited by 35
Yin, J., Zhong, C., Zhu, Z., Bu, X., Xu, T., Guo, L., Wang, X., Zhang, J., Cui, Y., Li, D., et al. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.01.011 · Cited by 35
Elevated Levels of Serum IL-17A in Community-Dwelling Women with Higher Depressive Symptoms
Tsuboi, H., Sakakibara, H., Minamida, Y., Tsujiguchi, H., Matsunaga, M., Hara, A., & Nakamura, H. (2018) · Behavioral Sciences · doi:10.3390/bs8110102 · Cited by 33
Li, Q., Xia, B., Wu, J., Yuan, X., Xu, L., Huang, C., Gu, H., Zheng, K., You, Q., & Liu, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.924174 · Cited by 32
Kovács, D., Gonda, X., Petschner, P., Édes, A. E., Eszlári, N., Bagdy, G., & Juhász, G. (2014) · Annals of General Psychiatry · doi:10.1186/1744-859x-13-17 · Cited by 31
Oxidative Stress in DNA Repeat Expansion Disorders: A Focus on NRF2 Signaling Involvement
Rosa, P. L., Petrillo, S., Bertini, E., & Piemonte, F. (2020) · Biomolecules · doi:10.3390/biom10050702 · Cited by 30
Chang, C., Lee, C.-T., Lan, T., Ju, P., Hsieh, Y., & Lai, T.-J. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.006 · Cited by 29
Mashhadi, N. S., Darand, M., Rouhani, M. H., Yahay, M., Feltham, B. A., & Saraf‐Bank, S. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114083 · Cited by 31
Ding, X., Liu, R., Li, W., Ni, H., Liu, Y. U., Wu, D., Yang, S., Liu, J., Xiao, B., & Liu, S. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9748-z · Cited by 29
Ignácio, Z. M., Réus, G. Z., Abelaira, H. M., de Moura, A. B., de Souza, T. G., Matos, D., Goldim, M. P. D. S., Mathias, K., Garbossa, L., Petronilho, F. C., et al. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0028-y · Cited by 29
Carotenoids and Neurobiological Health
Guest, J., & Grant, R. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_11 · Cited by 28
Takahashi, M., Lim, P. J., Tsubosaka, M., Kim, H., Miyashita, M., Suzuki, K., Tan, E. L., & Shibata, S. (2019) · Journal of Physical Therapy Science · doi:10.1589/jpts.31.408 · Cited by 27
Gliyazova, N. S., Huh, E. Y., & Ibeanu, G. C. (2013) · BMC Neuroscience · doi:10.1186/1471-2202-14-93 · Cited by 28
Czarny, P. L., Kwiatkowski, D., Toma, M. M., Gałecki, P., Orzechowska, A., Bobińska, K., Bielecka-Kowalska, A., Szemraj, J., Berk, M., Anderson, G., et al. (2016) · Medical Science Monitor · doi:10.12659/msm.898091 · Cited by 28
Magnesium Isoglycyrrhizinate attenuates lipopolysaccharide-induced depressive-like behavior in mice
Jiang, W., Chen, Q., Li, P., Lu, Q., Pei, X., Sun, Y., Wang, G., & Hao, K. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.033 · Cited by 27
Curcumin Reduces Depression in Obese Patients with Type 2 Diabetes: A Randomized Controlled Trial
Yaikwawong, M., Jansarikit, L., Jirawatnotai, S., & Chuengsamarn, S. (2024) · Nutrients · doi:10.3390/nu16152414 · Cited by 28
Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers
Wood, S. K. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00950 · Cited by 27
Adachi, Y., Toyoshima, K., Nishimoto, R., Ueno, S., Tanaka, T., Imaizumi, A., Arashida, N., Nakamura, M., Abe, Y., Hakamada, T., et al. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13585 · Cited by 25
Ji, H., Zhuang, Q., & Shen, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8202 · Cited by 24
Yu, Z., Jin, W., Dong, X., Ao, M., Liu, H., & Yu, L. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.104570 · Cited by 24
Yuluğ, B., Hanoğlu, L., Tavlı, A. M., lmaz, N. H. Y., & c, E. K. L. (2016) · Medicinal Chemistry · doi:10.2174/1573406411666151005110321 · Cited by 23
Gene Expression Profile in Major Depressive Disorder Shows Reduced Mitochondrial Biogenesis
Alcocer‐Gómez, E., Núñez‐Vasco, J., Casas‐Barquero, N., Williams, M. R., Navarro-Pando, J. M., Bullón, P., & Cordero, M. D. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12568 · Cited by 23
Jiang, M., & Zhao, H. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117807 · Cited by 26
Psychological Stress as a Modulator of Functional Recovery Following Spinal Cord Injury
Bouchard, S. M., & Hook, M. A. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00044 · Cited by 26
Manoliu, A., Bosch, O. G., Brakowski, J., Brühl, A. B., & Seifritz, E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.08.022 · Cited by 25
Sheffield, Z., Paul, P., Krishnakumar, S., & Pan, D. (2024) · Advanced Science · doi:10.1002/advs.202411339 · Cited by 24
Dietary antioxidants and fibre intake and depressive symptoms in Iranian adolescent girls
Khayyatzadeh, S. S., Omranzadeh, A., Miri-Moghaddam, M. M., Arekhi, S., Naseri, A., Ziaee, A., Khajavi, L., Salehkhani, F. N., Ferns, G. A., & Ghayour-Mobarhan, M. (2020) · Public Health Nutrition · doi:10.1017/s1368980020004838 · Cited by 23
Moreno-Quirós, C. V., Sánchez-Medina, A., Vázquez-Hernández, M., Reyes, A. G. H., & García-Rodríguez, R. V. (2017) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2017.10.007 · Cited by 22
Yin, S., Shao, J., Wang, X., Yin, X., Li, W., Gao, Y., de-la-Paz, O. I. V., Shi, H., & Li, S. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.08.037 · Cited by 21
Haleem, E. N. A. A., Ahmed, H. I., & El‐Naga, R. N. (2021) · Journal of Dietary Supplements · doi:10.1080/19390211.2021.1988797 · Cited by 21
Zhang, H., Zhang, G., & Fu, J. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.073 · Cited by 21
Kim, N., Sung, J. Y., Park, J. Y., Kong, I. D., Hughes, T. L., & Kim, D.-K. (2018) · Social Science & Medicine · doi:10.1016/j.socscimed.2018.12.026 · Cited by 20
Ghazizadeh, H., Saberi‐Karimian, M., Aghasizadeh, M., Sahebi, R., Ghazavi, H., Khedmatgozar, H., Timar, A., Rohban, M., Javandoost, A., & Ghayour‐Mobarhan, M. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100272 · Cited by 20
Condoleo, V., Bonfrate, L., Armentaro, G., Pelaia, C., Cassano, V., Marco, M. D., Severini, G., Pastura, C. A., Miceli, S., Maio, R., et al. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03220-z · Cited by 20
Abraúl, M., Alves, A., Hilário, S., Melo, T., Conde, T., Domingues, M. R., & Rey, F. (2023) · Marine Drugs · doi:10.3390/md21040199 · Cited by 22
Hirose, A., Terauchi, M., Tamura, M., Akiyoshi, M., Owa, Y., Kato, K., & Kubota, T. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0021-4 · Cited by 20
Gao, J., Xu, W., Han, K. S., Zhu, L., Gao, L., & Shang, X. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s149712 · Cited by 20
Tunç, S., Atagün, M. İ., Neşeli̇oğlu, S., Yenilmez, Y., Başbuğ, H. S., & Erel, Ö. (2018) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2018.1517466 · Cited by 20
Chávez-Castillo, M., Nava, M., Ortega, Á., Rojas, M., Núñez, V., Salazar, J. J., Bermúdez, V., & Rojas, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200413144401 · Cited by 21
Camargo, A., Dalmagro, A. P., Rosa, J. M., Zeni, A. L. B., Kaster, M. P., Tasca, C. I., & Rodrigues, A. L. S. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104797 · Cited by 19
The brain, rapid eye movement sleep, and major depressive disorder: A multimodal neuroimaging study
Liu, S., Chen, J., Guan, L., Li, X., Cai, H., Wang, J., Zhu, D., Zhu, J., & Yu, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111151 · Cited by 17
Liu, Y., Li, Y., Li, J., Hui, R., Sun, J., Xiu, J., & Wu, N. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118823 · Cited by 18
Atagün, M. İ., & Canbek, Ö. (2021) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2021.21584 · Cited by 17
Gomes, B. A. Q., dos Santos, S. M., Gato, L. D. S., Espíndola, K. M. M., da Silva, R. K. M., Davis, K., Navegantes-Lima, K. C., Burbano, R. M. R., Romão, P. R. T., Coleman, M. D., et al. (2025) · Nutrients · doi:10.3390/nu17050791 · Cited by 16
Guest, J., Grant, R., Garg, M. L., Mori, T. A., Croft, K. D., & BILGIN, A. A. B. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-117 · Cited by 15
Geletzke, A. K., Rinaldi, J. M., Phillips, B. E., Mobley, S. B., Miller, J., Dykes, T., Hollenbeak, C., Kelleher, S. L., & Soybel, D. I. (2014) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2431-y · Cited by 14
Drugs repurposing in the experimental models of Alzheimer’s disease
Joodi, S. A., Ibrahim, W. W., & Khattab, M. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-024-01608-7 · Cited by 14
Benedetti, S., Bucciarelli, S., Canestrari, F., Catalani, S., Mandolini, S., Marconi, V., Mastrogiacomo, A. R., Silvestri, R., Tagliamonte, M. C., Venanzini, R., et al. (2014) · Open Journal of Depression · doi:10.4236/ojd.2014.32011 · Cited by 13
Tsuboi, H., Sakakibara, H., Tatsumi, A., Yamakawa‐Kobayashi, K., Matsunaga, M., Kaneko, H., & Shimoi, K. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.02.031 · Cited by 14
Liang, C., Gałecki, P., & Su, K. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11175114 · Cited by 13
Urea Level and Depression in Patients with Chronic Kidney Disease
Levassort, H., Boucquemont, J., Lambert, O., Liabeuf, S., Laville, S. M., Teillet, L., Tabcheh, A.-H., Frimat, L., Combe, C., Fouque, D. P., et al. (2024) · Toxins · doi:10.3390/toxins16070326 · Cited by 12
Chen, Z., Huang, C., He, H., & Ding, W. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000307 · Cited by 12
Nogo, D., Wilkialis, L., Lui, L. M. W., Nasri, F., Rosenblat, J. D., & McIntyre, R. S. (2021) · Annals of Clinical Psychiatry · doi:10.12788/acp.0034 · Cited by 12
Quam bene vivas referre: curing and caring in psycho‐oncology
Grassi, L. G. (2013) · Psycho-Oncology · doi:10.1002/pon.3333 · Cited by 12
Biomarkers of Oxidative Stress in Major Depressive Disorder
Hamed, R. A., Elmalt, H. A., Salama, A., Abozaid, S. Y., & Ahmed, A. (2020) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2020.4144 · Cited by 12
Zhang, K., Wu, Y., Yi, L., Wu, Y., Deng, Y., Xu, X., Wang, B., Jiang, Y., Zhao, Q., & Zhao, G. (2025) · Nutrients · doi:10.3390/nu17060942 · Cited by 14
dos Santos, B. M., Pereira, G. C., Piton, E., Fialho, M. F. P., Becker, G., Carlotto, M. D. S., Camargo, L. F. M., Ramanzini, L. G., Oliveira, S. M., Trevisan, G., et al. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.113815 · Cited by 11
Rankin, J. S., Zalcman, S. S., Zhu, Y., & Siegel, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064473 · Cited by 10
Eustress, distress, and oxidative stress: Promising pathways for mind-body medicine
Aschbacher, K., & Mason, A. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00029-8 · Cited by 10
Ghaffari, S., Ghobadi, A., Jamshidi, A. H., Mortazavi, S. H., Naderi, S., Aqamolaei, A., Mortezaei, A., Sahebolzamani, E., Shamabadi, A., Jalilvand, S., et al. (2019) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2019.12.002 · Cited by 9
EFFECTS OF CINNAMOMUM ZEYLANICUM BARK EXTRACT ON NOCICEPTION AND ANXIETY LIKE BEHAVIOR IN MICE
Jain, S., & Gupta, S. (2019) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2019.v12i9.31287 · Cited by 10
Tsuboi, H., Sakakibara, H., Minamida, Y., Tsujiguchi, H., Hara, A., Suzuki, K., Miyagi, S., Nakamura, M., Takazawa, C., Kannon, T., et al. (2024) · BioPsychoSocial Medicine · doi:10.1186/s13030-024-00317-5 · Cited by 10
The P2X7 receptor in depression: Novel insights and therapeutic implications
Zhong, Y.-T., Pi, C., Zuo, Y., Yan, W., Li, W., Jiang, Y., Lei, T., Zheng, W., Jiang, J., Yang, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107011 · Cited by 11
Grounding clinical and cognitive scientists in an interdisciplinary discussion
Ottoboni, G. (2013) · Frontiers in Psychology · doi:10.3389/fpsyg.2013.00630 · Cited by 11
Mathew, B., Srinivasan, K., Johnson, P., Thomas, T. S., & Mandal, A. K. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_586_17 · Cited by 9
Chen, L., Li, D., Tang, K., Li, Z., & Huang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33832 · Cited by 8
Patel, A. N., Varma, J. R., & Ganguly, B. (2024) · Cureus · doi:10.7759/cureus.62991 · Cited by 8
Novel Therapeutic Targets for Major Depressive Disorder
Lazar, M. A., & McIntyre, R. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00034-2 · Cited by 9
Nutrition and Gastrointestinal Health as Modulators of Parkinson’s Disease
Rasmussen, H. E., Piazza, B., Forsyth, C. B., & Keshavarzian, A. (2014) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-06151-1_11 · Cited by 9
Grassi, L. G., Wise, T. N., Cockburn, D., Caruso, R., & Riba, M. (2018) · Integrating psychiatry and primary care · doi:10.1007/978-3-319-74736-1_2 · Cited by 13
Boldrini, M., & Mann, J. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00039-3 · Cited by 7
Oxidative Stress in Treatment-Resistant and Refractory Depression: A Hidden Therapeutic Target?
Winczewska, Z., Cubała, W. J., Radziwiłłowicz, P., & Górska‐Ponikowska, M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05715-0 · Cited by 7
de Aquino, G. Â., de Sousa, C. N. S., Medeiros, I. D. S., de Almeida, J. C., Filho, F. M. S. C., Júnior, M. A. S., & Vasconcelos, S. M. M. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2021-0056 · Cited by 7
Antidepressant and Anxiolytic Effects of Fermented Huauzontle, a Prehispanic Mexican Pseudocereal
Santiago‐López, L., Almada-Corral, A., Garcia, H. S., Mata‐Haro, V., González-Córdova, A. F., Vallejo‐Córdoba, B., & Hernández‐Mendoza, A. (2022) · Foods · doi:10.3390/foods12010053 · Cited by 7
Kamrani, F., Kachouei, A. A., Fereydouni, N., Tanbakuchi, D., Esmaily, H., Moohebati, M., Mahaki, H., Rezaee, A., Darroudi, S., Ghayour‐Mobarhan, M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.08.172 · Cited by 8
Lung Disease, Oxidative Stress, and Oxygen Requirements in Preterm Infants
Moore, T. A., Schmid, K. K., Anderson‐Berry, A., & Berger, A. M. (2015) · Biological Research For Nursing · doi:10.1177/1099800415611746 · Cited by 7
How does IL-6 change after combined treatment in MDD patients? A systematic review
Lombardi, A. L., Manfredi, L., & Conversi, D. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100579 · Cited by 7
Major depressive disorder: An organic disorder!
Yrondi, A., Sporer, M., Schmitt, L., & Arbus, C. (2018) · La Presse Médicale · doi:10.1016/j.lpm.2017.12.005 · Cited by 7
Zaman, N. I. U., Teh, L. K., Ahmad, R., Noorizhab, M. N. F., Rofiee, M. S., James, R. J., Nor, N. M., Mohamed, M. B., Hoon, T. S., Singh, P., et al. (2023) · Precision and Future Medicine · doi:10.23838/pfm.2022.00128 · Cited by 6
ROLE OF ENZYMES IN THE PATHOGENESIS OF DEPRESSION
Walia, V. (2016) · Journal of Critical Reviews · Cited by 5
Ali, A. A. (2016) · Acta Psychopathologica · doi:10.4172/2469-6676.100059 · Cited by 5
Suppression of cigarette smoke induced MMP1 expression by selective serotonin re‐uptake inhibitors
Adam, G., Shiomi, T., Goldklang, M. P., Sonett, J., Anguiano, V., Becky, M., Zelonina, T., & Jeanine, D. (2021) · The FASEB Journal · doi:10.1096/fj.202001966rr · Cited by 5
Walker, M. T., Bloodworth, J. C., Kountz, T. S., McCarty, S. L., Green, J. E., Ferrie, R. P., Campbell, J. A., Averill, S. H., Beckman, K. B., Grammer, L. C., et al. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1385168 · Cited by 4
Zhang, J., Li, A., He, Y., Guo, T., Ge, Y., Pan, H., & Dong, C. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1577126 · Cited by 6
Zhang, L., Li, S., Liu, S., & Wang, Z. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100836 · Cited by 4
MODERATE INTENSITY PHYSICAL EXERCISE: PSYCHONEUROIMMUNOLOGICAL ASPECTS
Fernandes, E. V., Estanislau, C. R., & Venâncio, E. J. (2018) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-869220182405185533 · Cited by 4
Metadata
- Authors
- Rawdin, B. J., Mellon, S. H., Dhabhar, F. S., Epel, E. S., Puterman, E., Su, Y., Burke, H. M., Reus, V. I., Rosser, R., Hamilton, S. P., Nelson, J. C., & Wolkowitz, O. M.
- Affiliations
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Corresponding author
- Wolkowitz, O.M.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 31
- Pages
- 143-152
- ISSN
- 0889-1591 (ISSN-L)
- PMC
- PMC3669232
- OpenAlex
- W2003062523
- Cited by
- 255
- References
- 126
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 18 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 21 · 2019: 25 · 2018: 21 · 2017: 20 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 12
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Brain Behavior and Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (R00HL109247)
- National Institute of Mental Health (R01MH083784, R25MH060482)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- major depressive disorder, chronic inflammation, oxidative stress, F2-isoprostanes, interleukin-6, IL-10, IL-6/IL-10 ratio, sertraline, antidepressant treatment, untreated depression
- MeSH terms
- Adult, Antidepressive Agents, Major Depressive Disorder, Depressive Disorder, Major, Female, Humans, Inflammation, Male, Middle Aged, Interleukin-6, Interleukin-10, Treatment Outcome, Oxidative Stress, Sertraline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review